Recomendaciones sobre diagnóstico, prevención y tratamiento farmacológico y no farmacológico de la osteoartritis (OA) de rodilla

Autores/as

DOI:

https://doi.org/10.28957/rcmfr.v27n2a4

Palabras clave:

osteoartritis, terapia farmacológica, prevención primaria

Resumen

Este documento reúne las recomendaciones sobre diagnóstico, prevención y tratamiento farmacológico y no farmacológico de la osteoartritis (OA) de rodilla, de acuerdo con el concepto de un grupo multidisciplinario de médicos colombianos expertos en el tema. Las recomendaciones dadas en este Position Statement están basadas en una extensa revisión no sistemática de la literatura acerca del tema

Referencias bibliográficas

1. Musumeci, G. et al. Osteoarthritis in the XXIst Century: Risk Factors and Behaviors that Influence Disease Onset and Progression. Int. J. Mol. Sci, 2015 ;16:6093-6112. DOI:10.3390/ijms16036093 www.mdpi.com/journal/ijms.

2. Hafez, A. R. et al. Knee Osteoarthritis: A Review of Literature. Phys Med Rehabil Int,2014;1(5).

3. Lawrence, R. C., Felson, D. T., Helmick, C. G. et al. Estimates of the Prevalence of Arthritis and Other Rheumatic Conditions in the United States. Part II. Arthritis Rheum, 2008;58(1):26-35. [PubMed: 18163497]. Mencionado por Zhang, Y. y J. M. Jordan. Epidemiology of Osteoarthritis. Clin Geriatr Med, 2010;26(3):355-369, agosto. DOI:10.1016/j.cger.2010.03.001.

4. Felson, D. T., Naimark, A., Anderson, J., Kazis, L., Castelli, W. y R. F. Meenan. The Prevalence of Knee Osteoarthritis in the Elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 1987;30:914-918. http://onlinelibrary.wiley.com/doi/10.1002/art.1780300811/pdf

5. Srikanth, V. K., Fryer, J. L., Zhai, G., Winzenberg, T. M., Hosmer, D. y G. Jones. A Meta-analysis of Sex Differences Prevalence, Incidence and Severity of Osteoarthritis. Osteoarthritis Cartilage. 2005;13:769-781. Mencionado en Hafez, A. R. et al. Knee Osteoarthritis: A Review of Literature. Phys Med Rehabil Int 2014;1(5).

6. Al-Shammari, S. A., Khoja, T. A., al-Maatouq, M. A. y L. A. al-Nuaim. High Prevalence of Clinical Obesity among Saudi Females: A Prospective, Cross-sectional Study in the Riyadh Region. J Trop Med Hyg, 1994;97:183- 188. Mencionado en Hafez, A. R. et al. Knee Osteoarthritis: A Review of Literature. Phys Med Rehabil Int 2014;1(5).

7. Nguyen, U. S., Zhang, Y., Zhu, Y., Niu, J., Zhang, B. y D. T. Felson. Increasing Prevalence of Knee Pain and Symptomatic Knee Osteoarthritis: Survey and Cohort Data. Ann Intern Med, 2011;155:725-732.

8. MacKay, C., Jaglal, S., Sale, J., Badley, E. M. y A. M. Davis (2014). A Qualitative Study of the Consequences of Knee Symptoms: ‘It’s like You’re an Athlete and You Go to a Couch Potato’. BMJ Open, 4:e006006.

9. Treatment of Osteoarthritis of the Knee Evidence-Based Guideline, 2.a ed. (2013). Adoptada por la American Academy of Orthopedic Surgeons Board of Directors, 18 de mayo. http://www.aaos.org/research/guidelines/TreatmentofOsteoarthritisoftheKneeGuideline.pdf

10. Felson, D. T., Lawrence, R. C., Dieppe, P. A. et al. Osteoarthritis: New Insights. Part 1: The Disease and its Risk Factors. Ann Intern Med 2000;133(8):635–646. [PubMed:11033593].

11. Barr, A. J., Dube, B., Hensor, E. M., Kingsbury, S. R., Peat, G., Bowes, M. A. y P. G. Conaghan. The Relationship between Clinical Characteristics, Radiographic Osteoarthritis and 3D Bone Area: Data from the Osteoarthritis Initiative, Osteoarthritis Cartilage 2014;22:1703-1709, octubre.

12. Kellgren, J. H. y J. S. Lawrence. Radiological Assessment of Osteoarthrosis. Ann Rheum Dis. 1957;16:494-502. Mencionado por Hafez, A.R. et al. Knee Osteoarthritis: A Review of Literature. Phys Med Rehabil Int 2014;1(5).

13. Burr, D. B. y E. L. Radin. Microfractures and Microcracks in Subchondral Bone: Are they Relevant to Osteoarthrosis? Rheum Dis Clin
North Am 2003;29:675-685.

14. Osteoarthritis: Care and Management (CG177). Nice Guideline Osteoarthritis: Care and Management. Clinical Guideline (2014). Publicada el 12 de febrero.nice.org.uk/guidance/cg177.

15. Espinosa Morales, R. et al. Reunión multidisciplinaria de expertos en diagnóstico y tratamiento de pacientes con osteoartritis. Actualización basada en evidencias. Med Int Mex 2013;29(1):67-92.

16. Case, R., Thomas, E., Clarke, E. y T. Peat. Prodromal Symptoms in Knee Osteoarthritis: A Nested Case-control Study Using Data from the Osteoarthritis Initiative. Osteoarthritis Cartilage 2015;23:1083-1089.

17. Bellamy, M., Buchanan, W., Goldsmith, C., Campbell, J. y L. Stitt. Validation Study of WOMAC: A Health Status Instrument for Measuring Clinically Important Patient Relevant Outcomes to Antirheumatic Drug Therapy in Patients with Osteoarthritis of the Hip or Knee. J Rheumatol 1988;15: 1833-1840.

18. Lequesne, M. G. The Algofunctional Indices for Hip and Knee Osteoarthritis. J Rheumatol, 1997;24:779-781.

19. Kellgren, J. y J. Lawrence (1963). Atlas of Standard Radiographs. The Epidemiology of Chronic Rheumatism, vol. 2. Oxford: Blackwell Scientific Publications. Mencionado por Zhang Y. y J. M. Jordan. Epidemiology of Osteoarthritis. Clin Geriatr Med agosto 2010;26(3):355-369. DOI:10.1016/j.cger.2010.03.001.

20. Demehri, S., Hafezi-Nejad, N. y J. A. Carrino. Conventional and Novel Imaging Modalities in Osteoarthritis: Current State of the Evidence. Curr Opin Rheumatol 2015;27:295-303.

21. Bruyn, G. A., Naredo, E. et al. An OMERACT Reliability Exercise of Inflammatory and Structural Abnormalities in Patients with
Knee Osteoarthritis Using Ultrasound Assessment. Ann Rheum Dis, 2016;75(5):842-846, mayo. DOI: 10.1136/annrheumdis-2014-206774. Publicación electrónica: 22 de abril del 2015.

22. Keen, H. I., Hensor, E. M. A. , Wakefield, R. J., Mease, P. J., Binham, C. O. y Conaghan P. G.. Ultrasound Assessment of Response to Intra–articular Therapy in Osteoarthritis of the Knee. Rheumatology (Oxford). Aug 2015;54(8):1385-91. DOI: 10.1093/rheumatology/keu529.

23. Jüni, P., Hari, R., Rutjes A. W., Fischer, R., Silletta M. G., Reichenbach, S. y B. R. da Costa (2015). Intra-articular Corticosteroid for Knee Osteoarthritis. Cochrane Database of Systematic Reviews.

24. Lotz, M., Pelletier, J. M., Christiansen, C. et al. Value of Biomarkers in Osteoarthritis: Current Status and Perspectives. Ann Rheum Dis 2013;72:1756-1763.

25. Espinosa Morales, R. et al. Reunión multidisciplinaria de expertos en diagnóstico y tratamiento de pacientes con osteoartritis. Actualización basada en evidencias. Med Int Mex 2013;29(1):67-92.

26. OARSI Guidelines for the Non-surgical Management of Knee Osteoarthritis. Osteoarthritis Cartilage, 2014;22:363-388. De las guías de la OARSI se deduce el primer lineamiento propuesto por el grupo para la
prevención de OA.

27. Fransen, M. y S. McConnell. Exercise for Osteoarthritis of the Knee. Cochrane Database Syst Rev 2008(4):CD004376. Publicación electrónica: 8 de octubre del 2008. Pub2.

28. Rosa, U. H. et al. Comparación de la eficacia del ejercicio terapéutico isocinético vs el isométrico en pacientes con artrosis de rodilla. Reumatol Clin 2012;8(1):10-14.

29. American Academy of Orthopedic Surgeons Clinical Practice Guideline on the Treatment of Osteoarthrosis of the Knee (Non Arthroplasty) (2008). Rosemont (Illinois): AAOS.

30. Jansen, M. J., Viechtbauer, W., Lenssen, A. F., Hendriks, E. J. M. y R. A. de Bie. Strength Training Alone, Exercise Therapy Alone, and Exercise Therapy with Passive Manual Mobilization Each Reduce Pain and Disability in People with Knee Osteoarthritis: A Systematic Review. J Physiother
2011;57:11-20.

31. Zhang, W., Nuki, G., Moskowitz, R. W. et al. OARSI Recommendations for the Management of Hip and Knee Osteoarthritis: Part III: Changes in Evidence Following Systematic Cumulative Update of Research Published through January 2009. Osteoarthritis Cartilage 2010;18(4):476-499, abril. DOI: 10.1016/j.joca.2010.01.013. Publicación electrónica: 11 de febrero del 2010.

32. Deyle, G. D., Allison, S. C., Matekel, R. L. et al. Physical Therapy Treatment Effectiveness for Osteoarthritis of the Knee: A Randomized Comparison of Supervised Clinical Exercise and Manual Therapy Procedures Versus a Home Exercise Program. Phys Ther 2005;85:1301-1317.

33. Rutjes, A. W., Nuesch, E., Sterchi, R. et al. Transcutaneous Electroestimulation for Osteoarthritis of the Knee. Cochrane Database Syst Rev 2009;(4):(CD002823).

34. Bjordal, J. M., Couppé, C., Chow, R. T.,Tuner, J. y A. E. Ljunggren. A Systematic Review of Low Level Laser Therapy with Locationspecific Doses for Pain from Joint Disorders. Aust J Physiother 2003;49: 107-116.

35. Atamaz, F. C., Durmaz, B., Baydar, M., Demircioglu, O. Y., Iyiyapici, A., Kuran, B., Oncel, S. y O. F. Sendur. Comparison of the Efficacy of Transcutaneous Electrical Nerve Stimulation, Interferential Currents, and Shortwave Diathermy in Knee Osteoarthritis: A Double-blind, Randomized, Controlled Multicenter Study. Arch Phys Med Rehabil 2012;93:748-756.

36. Silva, L. E., Valim V., Pessanha, A. P. C., Oliveira, L. M., Myamoto, S., Jones, A. y J. Natour. Hydrotherapy versus Conventional Land-Based Exercise for the Management of Patients With Osteoarthritis of the Knee: A Randomized Clinical Trial. Phys Ther 2008;88:12-21.

37. Forestier, R., Forestier, F. B. y A. Francon (2016). Spa Therapy and Knee Osteoarthritis: A Systematic Review. Ann Phys Rehabil Med, 59(3):216-226, junio. DOI: 10.1016/j.rehab.2016.01.010. Publicación electrónica:17 de marzo del 2016.

38. Richmond, J., Hunter, D. et al. American Academy of Orthopedic Surgeons Clinical Practice Guideline on the Treatment of Osteoarthritis (OA) of the Knee. J Bone Joint Surg Am 2010;92(4):990-993. DOI: 10.2106/JBJS.I.00982.

39. Jones, A., Silva, P. G., Silva, A. C., Colucci, M., Tuffanin, A., Jardim, J. R. y J. Natour. Impact of Cane Use on Pain, Function, General Health and Energy Expenditure during Gait in Patients with Knee Osteoarthritis: A Randomized Controlled Trial. Ann Rheum Dis 2012;71:172-179. DOI:10.1136/ard.2010.140178.

40. Jordan, A., Arden, N., Doherty, M. et al. EULAR Recommendations. An Evidence Based Approach to the Management of Knee Osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-1155.

41. Bannuru, R. R., Schmid, C. H., Kent, D. M., Vaysbrot, E. E., Wong, J. B. y T. E. McAlindon. Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis. Ann Intern Med 2015;162:46-54.

42. Towheed, T. E., Maxwell, L., Judd, M. G., Catton, M., Hochberg, M. C. y G. Wells (2006). Acetaminophen for osteoarthritis. Cochrane Database Syst Rev, 1:CD004257 [PMID: 16437479].

43. Krezelok, E. The FDA Acetaminophen Advisory Committee Meeting. What is the Future of Acetaminophen in the United States? The Perspective of a Committee Member. J Clin Toxicol 2009;47:784-789.

44. Hochberg, M., Altman, R., Toupin, K. et al. American College of Rheumatology 2012 Recommendations for the Use of Non pharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res 2012;64(4):465-474.

45. Bruyère, O., Cooper, C., Pelletier, J. P. et al. An Algorithm Recommendation for the Management of Knee Osteoarthritis in Europe and Internationally: A Report from a Task Force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014;44:253-263.

46. Altman, R. D. Pain Relief in Osteoarthritis: The Rationale for Combination Therapy. J Rheumatol 2004;31:5-7.

47. Solomon, D. H., Rassen, J. A., Glynn, R. J., Lee, J., Levin, R. y S. Schneeweiss (2010). The Comparative Safety of Analgesics in Older Adults with Arthritis. Arch Intern Med 2010;170:1968-1976.

48. Nüesch, E., Rutjes, A. W., Husni, E., Welch, V. y P. Jüni. Oral or Transdermal Opioids for Osteoarthritis of the Knee or Hip. Cochrane Database Syst Rev 2009. DOI: 7:CD003115.

49. Da Costa, B., Nüesch, E., Kasteler, E. et al. Oral or Transdermal Opioids for Osteoarthritis of the Knee or Hip. Cochrane Database Syst Rev 2014;9. Art. N.o CD003115.

50. Kjaersgaard-Andersen, P., Nafei, A., Skow, O., Madsen, F., Andersen, H. M., Kroner, K. et al. Codeine Plus Paracetamol in Longerterm Treatment of Chronic Pain Due to Osteoarthritis of the Hip: A Randomized, Double-blind, Multicentre Study. Pain 1990;43:309-318.

51. Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P. et al. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Non Cancer Pain. J Pain 2009;10:s113-130.

52. Cheung, C. W., Qiu, Q., Choi, S. W. et al. Chronic Opioid Therapy for Chronic Non-Cancer Pain: A Review and Comparison of Treatment Guidelines. Pain Physician 2014;17:401-414.

53. Singh, J., Noorbaloochi, J., Mac Donald, R. y L. Maxwell. Chondroitin for Osteoarthritis. Cochrane Database Syst Rev 2015;1, Art. N.o CD005614.

54. Blotman, F., Maheu, E., Wulwik, A., Caspard, H. y A. López. Efficacy and Safety of Avocado/Soybean Unsaponifiables in the Treatment of Symptomatic Osteoarthritis of the Knee and Hip. A Prospective Multicenter, Three-month, Randomized, Double-blind, Placebo-controlled Trial. Rev Rheum (edición en inglés) 1997;64:825-834.

55. Fidelix, T. S. A., Soares, B. G. O. y V. F. Trevisani. Diacerein for Osteoarthritis. Cochrane Database Syst Rev 2014;(2):CD005117.

56. Dougados, M., Nguyen, M., Berdah, L. et al. Evaluation of the Structure-modifying Effects of Diacerein in Hip Osteoarthritis. Arthritis and Rheum 2001;44:2539-2547.

57. Agencia Española de Medicamentos y Productos Sanitarios. Ficha técnica Diacereína NORMON 50 mg. Madrid: Centro de Información
Online de Medicamentos de la AEMPS-CIMA 2016;1-11.

58. Kumar, S. et al. A Double-blind, Placebocontrolled, Randomized, Clinical Study on the Effectiveness of Collagen Peptide on Osteoarthritis. J Sci Food Agric 2015;15;95(4):702-707, marzo. DOI: 10.1002/jsfa.6752. Publicación electrónica: 24 de junio del 2014.

59. McAlindon, T. E. et al. Change in Knee Osteoarthritis Cartilage Detected by Delayed Gadolinium Enhanced Magnetic Resonance Imaging Following Treatment with Collagen Hydrolysate: A Pilot Randomized Controlled Trial. Osteoarthritis Cartilage 2011;19:399-405.

60. Crowley, D. C. et al. Safety and Efficacy of Undenatured Type II Collagen in the Treatment of Osteoarthritis of the Knee: A Clinical Trial. Int J Med Sci 2009;6.

61. OARSI Recommendations for the Management of Hip and Knee Osteoarthritis, Part II, Consensus Guidelines, Osteoarthritis Cartilage 2008;16:137-162.

62. Arroll, B. y F. Goodyear–Smith. Corticosteroids Injection for Osteoarthritis of the Knee. BMJ, (2004). DOI:10.1136/bmj.38039. 573970.7C (published 23 March 2004).

63. Rillo, O. et al. PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and Knee. JCR octubre 2016;22(7).

64. Ghosh, P. y D. Guidolin. Potential Mechanism of Action of Intra-articular Hyaluronan Therapy in Osteoarthritis: Are the Effects Molecular Weight Dependent? Semin Arthritis Rheum 2002;32.

65. Balazs, A., Denlinger, J. L. Viscosupplementation: A New Concept in the Treatment of Osteoarthritis. J Rheumatol Suppl 1993;39:3-9.

66. Henrotin, Y. et al. Consensus Statement on Viscosupplementation with Hyaluronic Acid for the Management of Osteoarthritis. Semin Arthritis Rheum octubre de 2015;45(2):140-149.

67. Bellamy, N., Campbell, J., Robinson, V. et al. Viscosupplementation for the Treatment of Osteoarthritis of the Knee. The Cochrane Database Syst Rev 2006. Art. N.o CD005321, http://dx.doi.org/10.1002/14651858 [Art. No.: CD005321.pub2.CD005321.pub2].

68. Bannuru, R. R., Natov, N. S., Dasi, U. R. et al. Therapeutic Trajectory Following Intraarticular Hyaluronic Acid Injection in Knee Osteoarthritis Meta-analysis. Osteoarthritis Cartilage 2011;19:611-619.

69. Wang, C. T., Lin, J., Change, C. J. et al. Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the Knee. A Meta-analysis of Randomized Controlled Trials. J Bone Joint Surg 2004;86:538-545.

70. Divine, J. G., Zazulak, B. T. y T. E. Hewett. Viscosupplementation for Knee Osteoarthritis: A Systematic Review. Clin Orthop Relat Res 2007;455:113-122.

71. Miller, L. E. y J. E. Block. US-approved Intraarticular Hyaluronic Acid Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Metaanalysis of Randomized Saline-controlled Trials. Clin Med Insights Arthritis Musculoskelet Disord 2013;6:57-63.

72. Bannuru, R. R., Vaysbrot, E. E., Sullivan, M. C. y T. E. McAlindon. Relative Efficacy of Hyaluronic Acid in Comparison with NSAIDs for Knee Osteoarthritis: A Systematic Review and Meta-analysis. Semin Arthritis Rheum 2014;43:593-599.

73. Waddell, D. D. y B. Joseph. Delayed Total Knee Replacement with Hylan G-F 20. J Knee Surg, 2016;29(2):159–168. Publicación electrónica: 2 de octubre del 2014.

74. Richette, P., Chevalier, X., Ea, H. K. et al. Hyaluronan for Knee Osteoarthritis: An Updated Meta-analysis of Trials with Low Risk of Bias. RMD open 2015;1(1):e000071. DOI: 10.1136/rmdopen-2015-000071.

75. Strauss, E. J., Hart, J. A., Miller, M. D., Altman, R. D. y J. E. Rosen. Hyaluronic Acid Viscosupplementation and Osteoarthritis. Am J Sports Med 2009;37:1636-1644. DOI: 10.1177/0363546508326984.

76. Leopold, S. S., Redd, B. B., Warme, W. J., Wehrle, P. A., Pettis, P. D. y S. Shott. Corticosteroid Compared with Hyaluronic Acid Injections for the Treatment of Osteoarthritis of the Knee. A Prospective, Randomized Trial. J Bone Joint Surg Am Julio de 2003;85-A(7):1197-1203. 16. Osteoarthritis: Care and Management (CG177). Nice Guideline Osteoarthritis: Care and Management. Clinical Guideline (2014). Publicada el 12 de febrero. nice. org.uk/guidance/cg177.

77. Wobig, M., Dickhut, A., Maier, R. et al. Viscosupplementation with Hylan G-F 20: A 26-week Controlled Trial of Efficacy and Safety in the Osteoarthritic Knee. Clin Ther 1998;20:410-423.

78. Waddell, D. D. y B. Joseph. Delayed Total Knee Replacement with Hylan G-F 20. J Knee Surg, 2016;29(2):159-168. Publicación electrónica: 2 de octubre del 2014.

79. Rutjes, A. W., Jüni, P., daCosta, B. R. et al. Viscosupplementation for Osteoarthritis of the Knee: A Systematic Review and Metaanalysis. Ann Intern Med 2012;157:180-191.

80. Lindqvist, U., Tolmachev, V., Kairemo, K., Aström, G., Jonsson, E. y H. Lundqvist. Elimination of Stabilized Hyaluronan from the Knee Joint in Healthy Men. Clin Pharmacokinet 2002;4:603-613.

81. Larsen, N. E., Dursema, H. D., Pollak, C. T. y E. M. Skrabut (2011). Clearance Kinetics of a Hylan-based Viscosupplement after Intra-articular and Intravenous Adminis tration in Animal Models. J Biomed Mater Res B Appl Biomater, 31971, http://dx.doi.org/10.1002/jbm.b.

82. Lin, J., Zhang, W., Jones, A. y M. Doherty. Efficacy of Topical Non-steroidal Antiinflammatory Drugs in the Treatment of Osteoarthritis: Meta-analysis of Randomized Controlled Trials. BMJ, 2004;329(7461):324-326.

Cómo citar

1.
Chalem Choueka M, Arango Pilonieta CE, Díaz Cortés ME, Duperly Sánchez J, Forero Franco JP, Llinás Hernández PJ, et al. Recomendaciones sobre diagnóstico, prevención y tratamiento farmacológico y no farmacológico de la osteoartritis (OA) de rodilla. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 21 de febrero de 2018 [citado 18 de abril de 2024];27(2):160-84. Disponible en: https://revistacmfr.org/index.php/rcmfr/article/view/196

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2018-02-21

Número

Sección

Revisión sistemática
QR Code

Algunos artículos similares: